Visceral Larva Migrans (Toxocara canis - Systemic Migration)

Overview


Plain-Language Overview

Visceral Larva Migrans (VLM) is an infection caused by the larvae of the roundworm Toxocara canis, which primarily affects the internal organs such as the liver, lungs, and sometimes the brain. This condition occurs when the larvae migrate through the body after being ingested, leading to inflammation and damage in various tissues. The immune system reacts strongly, causing symptoms like fever, cough, and abdominal pain. It mainly affects children who accidentally swallow contaminated soil or dirt containing the parasite eggs. The disease can cause significant discomfort and may lead to complications if the larvae invade critical organs. Diagnosis often involves blood tests and imaging to detect the presence of the parasite and the body's response.

Clinical Definition

Visceral Larva Migrans (VLM) is a systemic parasitic infection caused by the larval migration of Toxocara canis, a nematode commonly found in dogs. After ingestion of embryonated eggs, larvae hatch in the intestine and penetrate the intestinal wall, entering the bloodstream to migrate through various visceral organs including the liver, lungs, and central nervous system. The host immune response, characterized by eosinophilia and granulomatous inflammation, leads to tissue damage and clinical manifestations such as hepatomegaly, pulmonary symptoms, and sometimes neurological signs. VLM is significant due to its potential to cause chronic organ damage and systemic illness, especially in children with high exposure risk. Diagnosis relies on clinical suspicion, serologic testing, and exclusion of other causes of eosinophilia and organomegaly.

Inciting Event

  • Ingestion of embryonated Toxocara canis eggs from contaminated soil or objects.

  • Accidental ingestion of dirt or sand containing infective larvae.

  • Contact with dog feces harboring Toxocara eggs leading to oral contamination.

  • Consumption of unwashed vegetables or fruits contaminated with embryonated eggs.

Latency Period

  • Symptoms typically develop within 1 to 3 weeks after ingestion of infective eggs.

  • Larval migration and immune response cause a variable latency before clinical presentation.

  • Some cases may have a prolonged asymptomatic period before systemic symptoms appear.

Diagnostic Delay

  • Nonspecific symptoms such as fever, malaise, and cough often mimic other common illnesses.

  • Lack of awareness about visceral larva migrans in non-endemic areas delays consideration.

  • Eosinophilia may be attributed to allergies or other parasitic infections without further workup.

  • Serologic testing is not routinely performed early, leading to missed or delayed diagnosis.

Clinical Presentation


Signs & Symptoms

  • Fever and fatigue are common systemic symptoms.

  • Abdominal pain and hepatomegaly result from liver involvement.

  • Cough, wheezing, and dyspnea occur with pulmonary larva migration.

  • Eosinophilia-associated rash or urticaria may be present.

  • Visual disturbances or eye pain suggest ocular larva migrans.

History of Present Illness

  • Initial presentation often includes prolonged fever, fatigue, and weight loss.

  • Abdominal pain and hepatomegaly develop due to liver involvement.

  • Respiratory symptoms such as cough and wheezing may occur from pulmonary larval migration.

  • Patients frequently report history of soil exposure or contact with puppies.

  • Symptoms may wax and wane as larvae migrate through different organs.

Past Medical History

  • History of pica or geophagia increases risk of ingestion of infective eggs.

  • Previous exposure to dogs or puppies known to carry Toxocara canis.

  • No specific chronic illnesses are required but immunocompetence influences disease course.

  • Lack of prior antihelminthic treatment may predispose to symptomatic infection.

Family History

  • No known heritable predisposition or familial syndromes associated with visceral larva migrans.

  • Family members may share environmental exposure risks if living in contaminated areas.

  • Clusters of cases can occur in families due to shared exposure to contaminated soil or pets.

Physical Exam Findings

  • Hepatomegaly due to liver inflammation is a common finding in visceral larva migrans.

  • Fever and generalized lymphadenopathy may be present reflecting systemic immune response.

  • Wheezing or rales can be auscultated if pulmonary involvement occurs.

  • Eosinophilic infiltration may cause palpable subcutaneous nodules or rash.

  • Conjunctival injection or ocular inflammation may be noted if ocular larva migrans coexists.

Diagnostic Workup


Diagnostic Criteria

Diagnosis of visceral larva migrans is established by a combination of clinical features including eosinophilia, history of exposure to contaminated soil or dogs, and positive serologic tests such as enzyme-linked immunosorbent assay (ELISA) for Toxocara antibodies. Imaging studies like ultrasound or CT may reveal hepatomegaly or pulmonary infiltrates consistent with larval migration. Definitive diagnosis is supported by serology in the appropriate clinical context, as direct visualization of larvae is rare.

Pathophysiology


Key Mechanisms

  • Systemic migration of Toxocara canis larvae causes a robust eosinophilic inflammatory response in affected tissues.

  • Larval secretory antigens trigger a type 2 hypersensitivity reaction leading to tissue damage and granuloma formation.

  • Larvae do not mature in humans, resulting in prolonged tissue migration and chronic inflammation.

  • Infiltration of eosinophils and macrophages causes organ-specific damage such as hepatomegaly and pneumonitis.

  • Immune complex deposition may contribute to systemic symptoms like fever and malaise.

InvolvementDetails
Organs

Liver is the primary organ involved in visceral larva migrans with granulomatous inflammation and hepatomegaly

Lungs are frequently affected causing cough, wheezing, and eosinophilic infiltrates

Central nervous system involvement is rare but can cause neurological symptoms due to larval migration

Tissues

Liver tissue is commonly affected by larval migration causing granulomatous inflammation and hepatomegaly

Lung tissue involvement leads to eosinophilic pneumonitis and respiratory symptoms

Eye tissue can be affected in ocular larva migrans, causing visual impairment

Cells

Eosinophils mediate tissue inflammation and damage during larval migration in visceral larva migrans

Macrophages phagocytose larval debris and contribute to granuloma formation

T-helper 2 cells orchestrate the immune response by producing cytokines that recruit eosinophils

Chemical Mediators

Interleukin-5 (IL-5) promotes eosinophil proliferation and activation in response to larval antigens

Eosinophil cationic protein contributes to larval killing and tissue injury

IgE antibodies facilitate recognition of larvae and mediate hypersensitivity reactions

Treatments


Pharmacological Treatments

  • Albendazole

    • Mechanism:
      • Inhibits microtubule polymerization in larvae, impairing glucose uptake and leading to parasite death

    • Side effects:
      • Hepatotoxicity

      • Gastrointestinal upset

      • Leukopenia

    • Clinical role:
      • First-line

  • Mebendazole

    • Mechanism:
      • Disrupts microtubule formation in larvae, blocking nutrient absorption and causing parasite death

    • Side effects:
      • Gastrointestinal discomfort

      • Elevated liver enzymes

      • Neutropenia

    • Clinical role:
      • Second-line

  • Corticosteroids

    • Mechanism:
      • Suppresses host inflammatory response to migrating larvae, reducing tissue damage and symptoms

    • Side effects:
      • Immunosuppression

      • Hyperglycemia

      • Osteoporosis

    • Clinical role:
      • Adjunctive

Non-pharmacological Treatments

  • Supportive care including hydration and symptomatic management of fever and eosinophilia

  • Avoidance of exposure to contaminated soil or feces to prevent reinfection

Prevention


Pharmacological Prevention

  • Regular anthelmintic treatment with albendazole or mebendazole in high-risk populations reduces infection risk.

  • Deworming of domestic dogs with antihelminthics interrupts the Toxocara canis life cycle.

  • Prophylactic use of corticosteroids is not standard but may reduce severe inflammatory responses in some cases.

Non-pharmacological Prevention

  • Avoidance of soil contaminated with dog feces reduces exposure to infective larvae.

  • Proper hand hygiene after outdoor activities prevents ingestion of embryonated eggs.

  • Public health measures including dog population control and feces disposal decrease environmental contamination.

  • Education on safe play practices for children in endemic areas lowers infection rates.

  • Washing and peeling vegetables before consumption prevents ingestion of contaminated soil.

Outcome & Complications


Complications

  • Severe eosinophilic pneumonitis can cause respiratory distress.

  • Granulomatous hepatitis may lead to liver dysfunction.

  • Ocular larva migrans can cause vision loss or retinal damage.

  • Neurologic involvement may result in seizures or encephalitis.

  • Hypersensitivity reactions can cause systemic allergic manifestations.

Short-term Sequelae Long-term Sequelae
  • Persistent eosinophilia and systemic inflammation may last weeks to months.

  • Transient hepatomegaly and abdominal tenderness often resolve with treatment.

  • Pulmonary symptoms such as cough and wheezing typically improve after larval death.

  • Cutaneous manifestations may persist briefly due to immune response.

  • Mild anemia can occur secondary to chronic inflammation.

  • Chronic granulomatous inflammation may cause hepatic fibrosis in severe cases.

  • Permanent visual impairment can result from untreated ocular larva migrans.

  • Pulmonary fibrosis is a rare consequence of prolonged larval migration.

  • Neurologic deficits may persist if central nervous system involvement occurred.

  • Allergic sensitization may predispose to future atopic diseases.

Differential Diagnoses


Visceral Larva Migrans (Toxocara canis - Systemic Migration) versus Toxoplasmosis

Visceral Larva Migrans (Toxocara canis - Systemic Migration)

Toxoplasmosis

Exposure to soil contaminated with dog feces

Exposure to cat feces or undercooked meat

Hepatic or pulmonary granulomas with eosinophilia

Multiple ring-enhancing brain lesions on MRI

Marked peripheral eosinophilia and positive serology for Toxocara canis

Positive IgG and IgM antibodies against Toxoplasma gondii

Visceral Larva Migrans (Toxocara canis - Systemic Migration) versus Strongyloidiasis

Visceral Larva Migrans (Toxocara canis - Systemic Migration)

Strongyloidiasis

Ingestion of embryonated eggs from dog feces in contaminated soil

Contact with contaminated soil in tropical regions

Usually self-limited systemic migration in children with eosinophilia

Chronic infection with potential hyperinfection in immunocompromised hosts

Negative stool exam; diagnosis by serology or tissue biopsy

Detection of larvae in stool samples

Visceral Larva Migrans (Toxocara canis - Systemic Migration) versus Visceral Leishmaniasis

Visceral Larva Migrans (Toxocara canis - Systemic Migration)

Visceral Leishmaniasis

Exposure to environments contaminated with dog feces containing Toxocara eggs

Travel to endemic areas with sandfly exposure

Marked eosinophilia with leukocytosis

Pancytopenia with hypergammaglobulinemia

Positive serology for Toxocara canis or biopsy showing larvae

Identification of amastigotes in bone marrow aspirate

Visceral Larva Migrans (Toxocara canis - Systemic Migration) versus Hypereosinophilic Syndrome

Visceral Larva Migrans (Toxocara canis - Systemic Migration)

Hypereosinophilic Syndrome

Eosinophilia associated with positive parasitic serology

Sustained eosinophilia >1500 cells/μL without parasitic infection

Acute or subacute systemic symptoms following exposure to contaminated soil

Chronic progressive organ damage without clear infectious cause

Serologic evidence of Toxocara canis infection and tissue larvae

Bone marrow biopsy showing clonal eosinophilic proliferation

Visceral Larva Migrans (Toxocara canis - Systemic Migration) versus Schistosomiasis

Visceral Larva Migrans (Toxocara canis - Systemic Migration)

Schistosomiasis

Ingestion of embryonated eggs from dog feces in contaminated soil

Freshwater exposure in endemic regions with cercariae penetration

Hepatic or pulmonary granulomas without fibrosis

Bladder wall thickening or periportal fibrosis on ultrasound

Negative stool and urine exams; diagnosis by serology or biopsy

Detection of eggs in urine or stool samples

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.